Lazard Asset Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-86,771
Closed -$2.11M 2568
2024
Q4
$2.11M Buy
86,771
+65,912
+316% +$1.88M ﹤0.01% 862
2024
Q3
$774K Buy
+20,859
New +$778K ﹤0.01% 1200
2024
Q2
Sell
-31
Closed -$1K 2419
2024
Q1
$1K Sell
31
-690
-96% -$22.4K ﹤0.01% 1997
2023
Q4
$22K Sell
721
-168
-19% -$6.04K ﹤0.01% 2048
2023
Q3
$35K Sell
889
-1,429
-62% -$66.9K ﹤0.01% 1957
2023
Q2
$121K Sell
2,318
-1,226
-35% -$74.7K ﹤0.01% 1507
2023
Q1
$226K Buy
3,544
+837
+31% +$54.6K ﹤0.01% 1276
2022
Q4
$131K Buy
2,707
+1,932
+249% +$121K ﹤0.01% 1425
2022
Q3
$54K Buy
775
+91
+13% +$7.79K ﹤0.01% 1769
2022
Q2
$48K Hold
684
﹤0.01% 1834
2022
Q1
$54K Buy
684
+388
+131% +$28.9K ﹤0.01% 1704
2021
Q4
$27K Sell
296
-14,438
-98% -$1.55M ﹤0.01% 1974
2021
Q3
$1.89M Buy
14,734
+14,407
+4,406% +$2.02M ﹤0.01% 922
2021
Q2
$49K Buy
+327
New +$43.1K ﹤0.01% 1609
2020
Q3
Sell
-3,573
Closed -$219K 1736
2020
Q2
$219K Sell
3,573
-623
-15% -$25.4K ﹤0.01% 915
2020
Q1
$135K Buy
4,196
+2,675
+176% +$90.1K ﹤0.01% 955
2019
Q4
$53K Buy
1,521
+806
+113% +$26.6K ﹤0.01% 1042
2019
Q3
$18K Buy
+715
New +$21.7K ﹤0.01% 1106

Other funds holding STAA

Lazard Asset Management's STAA Position: Q1 2025 in Review

Lazard Asset Management sold out of STAAR Surgical (STAA) in Q1 2025, closing a stake of 86,771 shares — an estimated $2.11M sold.

Lazard Asset Management first reported a position in STAA in Q3 2019 and held it in 18 quarters. The position peaked at $2.11M in Q4 2024. 185 funds tracked by Wall St. Rank hold STAA as of Q1 2025.

  • Lazard Asset Management reported no remaining STAAR Surgical position as of Q1 2025 after selling out during the quarter.
  • Lazard Asset Management sold 86,771 STAAR Surgical shares in Q1 2025, an estimated $2.11M.
  • Lazard Asset Management first reported a position in STAAR Surgical in Q3 2019 and held it in 18 quarters.
  • Lazard Asset Management's STAAR Surgical position peaked at $2.11M in Q4 2024.
  • 185 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2025.

Based on Lazard Asset Management's 13F filing for Q1 2025, filed 15 May 2025.